Expression of Serum Sialic Acid, Early Antigen-IgA, and Viral Capsid Antigen-IgA in Nasopharynx Cancer Patients: The Diagnostic Implication of Combined Assays

about

Expression of Serum Sialic Acid, Early Antigen-IgA, and Viral Capsid Antigen-IgA in Nasopharynx Cancer Patients: The Diagnostic Implication of Combined Assays

Item

http://www.wikidata.org/entity/Q36425762

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Expression of Serum Sialic Aci ...... Implication of Combined Assays

@ast

Expression of Serum Sialic Aci ...... Implication of Combined Assays

@en

type

Item

label

Expression of Serum Sialic Aci ...... Implication of Combined Assays

@ast

Expression of Serum Sialic Aci ...... Implication of Combined Assays

@en

prefLabel

Expression of Serum Sialic Aci ...... Implication of Combined Assays

@ast

Expression of Serum Sialic Aci ...... Implication of Combined Assays

@en

P1476

Expression of Serum Sialic Aci ...... Implication of Combined Assays

@en

P2093

Caibo Sun

http://www.w3.org/2001/XMLSchema#string

Endong Zhang

http://www.w3.org/2001/XMLSchema#string

Yuning Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up.

Evaluation of a PCR/ESI-MS platform to identify respiratory viruses from nasopharyngeal aspirates.

[Nasopharyngeal carcinoma. Brush biopsy with EBV-PCR is suitable as a screening test].

Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.

Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.

Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma.

EA-D p45-IgG as a potential biomarker for nasopharyngeal carcinoma diagnosis.

Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma.

[The following-up study of high-risk and moderate-risk groups defined by EB virus serology test at the nasopharyngeal carcinoma screening programme].

Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.

P304

4068-4073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.894951

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26709095

http://www.w3.org/2001/XMLSchema#string

P932

4699620

http://www.w3.org/2001/XMLSchema#string